See more : Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Gusbourne PLC (SLLFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Gusbourne PLC, a leading company in the Beverages – Wineries & Distilleries industry within the Consumer Defensive sector.
- Ferrari N.V. (RACE.SW) Income Statement Analysis – Financial Results
- Takeda Pharmaceutical Company Limited (TAK) Income Statement Analysis – Financial Results
- Kintavar Exploration Inc. (KTR.V) Income Statement Analysis – Financial Results
- International Stem Cell Corporation (ISCO) Income Statement Analysis – Financial Results
- Megastar Foods Limited (MEGASTAR.NS) Income Statement Analysis – Financial Results
Gusbourne PLC (SLLFF)
Industry: Beverages - Wineries & Distilleries
Sector: Consumer Defensive
Website: https://www.gusbourne.com
About Gusbourne PLC
Gusbourne PLC, together with its subsidiaries, produces, distributes, and sells English sparkling wines in the United Kingdom. The company has 231 acres of vineyards in Kent and West Sussex. Gusbourne PLC was formerly known as Shellproof Plc and changed its name to Gusbourne PLC in September 2013. The company was incorporated in 2012 and is headquartered in Ashford, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.05M | 6.24M | 4.19M | 2.11M | 1.65M | 1.26M | 998.00K | 640.00K | 473.00K | 434.00K | 129.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 2.29M | 2.55M | 1.85M | 879.00K | 735.00K | 560.00K | 381.00K | 423.00K | 325.00K | 361.00K | -1.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 4.76M | 3.70M | 2.34M | 1.23M | 918.00K | 701.00K | 617.00K | 217.00K | 148.00K | 73.00K | 130.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 67.53% | 59.22% | 55.93% | 58.32% | 55.54% | 55.59% | 61.82% | 33.91% | 31.29% | 16.82% | 100.78% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.14M | 5.56M | 4.40M | 3.20M | 2.90M | 2.25M | 1.76M | 1.39M | 1.18M | 918.00K | 494.00K | 133.00K | 64.00K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -638.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.14M | 5.56M | 4.40M | 3.20M | 2.90M | 1.61M | 1.76M | 1.39M | 1.18M | 918.00K | 494.00K | 133.00K | 64.00K | 0.00 | 0.00 |
| Other Expenses | 0.00 | -239.00K | -704.00K | -221.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 152.00K | 169.00K | 0.00 | 0.00 |
| Operating Expenses | 6.14M | 5.56M | 4.40M | 3.20M | 2.90M | 2.25M | 1.76M | 1.39M | 1.18M | 918.00K | 611.00K | 143.00K | 65.00K | 56.00K | 114.00K |
| Cost & Expenses | 8.43M | 8.11M | 6.24M | 4.08M | 3.64M | 2.81M | 2.14M | 1.81M | 1.50M | 1.28M | 610.00K | 143.00K | 65.00K | 56.00K | 114.00K |
| Interest Income | 1.63M | 496.00K | 817.00K | 877.00K | 445.00K | 0.00 | 0.00 | 13.00K | 9.00K | 24.00K | 156.00K | 0.00 | 0.00 | 161.00K | 167.00K |
| Interest Expense | 0.00 | 496.00K | 817.00K | 877.00K | 445.00K | 347.00K | 469.00K | 282.00K | 205.00K | 218.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 661.00K | 601.00K | 600.00K | 647.00K | 699.00K | 638.00K | 479.00K | 357.00K | 267.00K | 130.00K | 18.00K | 8.00K | 0.00 | 0.00 | 0.00 |
| EBITDA | -1.23M | -1.54M | -2.20M | -1.58M | -1.46M | -786.00K | -695.00K | -889.00K | -954.00K | -753.00K | -460.00K | -135.00K | -65.00K | -56.00K | -114.00K |
| EBITDA Ratio | -17.41% | -20.23% | -34.67% | -62.64% | -77.74% | -71.93% | -66.43% | -140.31% | -157.29% | -157.14% | -458.91% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.38M | -2.10M | -2.76M | -2.19M | -2.16M | -1.42M | -1.17M | -1.16M | -1.12M | -919.00K | -610.00K | -143.00K | -65.00K | -56.00K | -114.00K |
| Operating Income Ratio | -19.51% | -33.69% | -65.76% | -103.79% | -130.43% | -112.61% | -117.13% | -181.09% | -237.42% | -211.75% | -472.87% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.63M | -496.00K | -817.00K | -877.00K | -445.00K | -347.00K | -469.00K | -369.00K | -303.00K | -232.00K | 48.00K | 152.00K | 169.00K | 161.00K | 167.00K |
| Income Before Tax | -3.00M | -2.60M | -3.57M | -3.07M | -2.60M | -1.77M | -1.64M | -1.53M | -1.43M | -1.10M | -454.00K | 9.00K | 104.00K | 105.00K | 53.00K |
| Income Before Tax Ratio | -42.58% | -41.63% | -85.25% | -145.38% | -157.35% | -140.13% | -164.13% | -238.75% | -301.48% | -254.38% | -351.94% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -38.00K | -74.00K | 704.00K | 221.00K | 172.00K | -125.00K | 27.00K | -96.00K | 112.00K | -60.00K | 60.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.97M | -2.53M | -3.57M | -3.07M | -2.60M | -1.77M | -1.64M | -1.53M | -1.43M | -1.04M | -454.00K | 9.00K | 104.00K | 105.00K | 53.00K |
| Net Income Ratio | -42.04% | -40.45% | -85.25% | -145.38% | -157.35% | -140.13% | -164.13% | -238.75% | -301.48% | -240.55% | -351.94% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.05 | -0.04 | -0.07 | -0.06 | -0.06 | -0.05 | -0.05 | -0.06 | -0.07 | -0.07 | -0.06 | 0.00 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | -0.05 | -0.04 | -0.07 | -0.06 | -0.06 | -0.04 | -0.05 | -0.06 | -0.07 | -0.07 | -0.06 | 0.00 | 0.01 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 60.64M | 60.60M | 48.99M | 47.76M | 47.12M | 38.25M | 31.14M | 23.64M | 20.89M | 15.59M | 8.22M | 8.22M | 8.22M | 8.22M | 8.22M |
| Weighted Avg Shares Out (Dil) | 60.64M | 60.60M | 48.99M | 47.76M | 47.12M | 39.32M | 32.03M | 24.29M | 21.47M | 16.02M | 8.22M | 8.22M | 8.22M | 8.22M | 8.22M |
Source: https://incomestatements.info
Category: Stock Reports